Human Gene WT1 (ENST00000452863.10_10) from GENCODE V47lift37
  Description: WT1 transcription factor, transcript variant D (from RefSeq NM_024426.6)
Gencode Transcript: ENST00000452863.10_10
Gencode Gene: ENSG00000184937.17_18
Transcript (Including UTRs)
   Position: hg19 chr11:32,409,321-32,457,085 Size: 47,765 Total Exon Count: 10 Strand: -
Coding Region
   Position: hg19 chr11:32,410,604-32,456,906 Size: 46,303 Coding Exon Count: 10 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesGeneReviewsModel Information
Methods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr11:32,409,321-32,457,085)mRNA (may differ from genome)Protein (522 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedUniProtKB
WikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: WT1_HUMAN
DESCRIPTION: RecName: Full=Wilms tumor protein; AltName: Full=WT33;
FUNCTION: Transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA.
SUBUNIT: Homodimer. Interacts with WTIP. Interacts with actively translating polysomes. Detected in nuclear ribonucleoprotein (mRNP) particles. Interacts with HNRNPU via the zinc-finger region. Interacts with U2AF2. Interacts with CITED2 (By similarity). Interacts with ZNF224 via the zinc-finger region. Interacts with WTAP and SRY. Interacts with FAM123B/WTX. Interacts with RBM4.
SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus. Cytoplasm (By similarity). Note=Shuttles between nucleus and cytoplasm (By similarity).
SUBCELLULAR LOCATION: Isoform 1: Nucleus speckle.
SUBCELLULAR LOCATION: Isoform 4: Nucleus, nucleoplasm.
TISSUE SPECIFICITY: Expressed in the kidney and a subset of hematopoietic cells.
RNA EDITING: Modified_positions=281; Note=Partially edited.
DISEASE: Defects in WT1 are the cause of Frasier syndrome (FS) [MIM:136680]. FS is characterized by a slowly progressing nephropathy leading to renal failure in adolescence or early adulthood, male pseudohermaphroditism, and no Wilms tumor. As for histological findings of the kidneys, focal glomerular sclerosis is often observed. There is phenotypic overlap with Denys-Drash syndrome. Inheritance is autosomal dominant.
DISEASE: Defects in WT1 are the cause of Wilms tumor 1 (WT1) [MIM:194070]. WT is an embryonal malignancy of the kidney that affects approximately 1 in 10'000 infants and young children. It occurs both in sporadic and hereditary forms.
DISEASE: Defects in WT1 are the cause of Denys-Drash syndrome (DDS) [MIM:194080]. DDS is a typical nephropathy characterized by diffuse mesangial sclerosis, genital abnormalities, and/or Wilms tumor. There is phenotypic overlap with WAGR syndrome and Frasier syndrome. Inheritance is autosomal dominant, but most cases are sporadic.
DISEASE: Defects in WT1 are the cause of nephrotic syndrome type 4 (NPHS4) [MIM:256370]. A renal disease characterized clinically by proteinuria, hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure. Most patients with NPHS4 show diffuse mesangial sclerosis on renal biopsy, which is a pathologic entity characterized by mesangial matrix expansion with no mesangial hypercellularity, hypertrophy of the podocytes, vacuolized podocytes, thickened basement membranes, and diminished patency of the capillary lumen.
DISEASE: Defects in WT1 are a cause of Meacham syndrome (MEACHS) [MIM:608978]. Meacham syndrome is a rare sporadically occurring multiple malformation syndrome characterized by male pseudohermaphroditism with abnormal internal female genitalia comprising a uterus and double or septate vagina, complex congenital heart defect and diaphragmatic abnormalities.
DISEASE: Note=A chromosomal aberration involving WT1 may be a cause of desmoplastic small round cell tumor (DSRCT). Translocation t(11;22)(p13;q12) with EWSR1.
DISEASE: Defects in WT1 may be a cause of mesothelioma malignant (MESOM) [MIM:156240]. An aggressive neoplasm of the serosal lining of the chest. It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos.
MISCELLANEOUS: Presence of the KTS motif hinders interactions between DNA and zinc-finger 4.
SIMILARITY: Belongs to the EGR C2H2-type zinc-finger protein family.
SIMILARITY: Contains 4 C2H2-type zinc fingers.
SEQUENCE CAUTION: Sequence=AAB33443.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part; Sequence=CAA35956.1; Type=Erroneous initiation; Note=Translation N-terminally shortened; Sequence=CAA35956.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon; Sequence=CAC39220.3; Type=Erroneous initiation; Note=Translation N-terminally shortened; Sequence=CAI95758.2; Type=Erroneous initiation; Note=Translation N-terminally shortened; Sequence=CAI95759.2; Type=Erroneous initiation; Note=Translation N-terminally shortened;
WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL="http://atlasgeneticsoncology.org/Genes/WT1ID78.html";
WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/WT1";
WEB RESOURCE: Name=NIEHS-SNPs; URL="http://egp.gs.washington.edu/data/wt1/";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: WT1
Diseases sorted by gene-association score: denys-drash syndrome* (1714), wilms tumor susceptibility-5* (1713), frasier syndrome* (1709), meacham syndrome* (1688), nephrotic syndrome, type 4* (1200), diffuse mesangial sclerosis* (740), mesothelioma, somatic* (654), benign mesothelioma* (424), hereditary nephrotic syndromes* (400), sporadic idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis* (350), desmoplastic small round cell tumor* (275), familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis* (247), wt1-related disorders* (218), glomerulosclerosis, focal segmental, 1* (132), wilms tumor-aniridia-genital anomalies-retardation syndrome* (100), wagr syndrome* (73), nephrotic syndrome (32), adenomatoid tumor (31), chronic leukemia (23), female reproductive endometrioid cancer (23), skull base meningioma (21), leukemia, acute myeloid* (21), sex cord-gonadal stromal tumor (20), acute leukemia (19), septate vagina (19), congenital mesoblastic nephroma (19), familial wilms tumor (17), metanephric adenoma (17), focal segmental glomerulosclerosis (17), hereditary wilms' tumor (17), aniridia (16), peritoneal mesothelioma (16), sarcomatoid mesothelioma (16), clear cell sarcoma (16), granuloma inguinale (15), malignant biphasic mesothelioma (15), cerebellar angioblastoma (15), congenital diaphragmatic hernia (14), pseudohermaphroditism (14), ovarian serous carcinoma (14), fallopian tube carcinosarcoma (14), gonadoblastoma (13), uterine sarcoma (12), renal adenoma (12), malignant pleural mesothelioma (12), cystic nephroma (11), ovarian brenner tumor (11), ovarian small cell carcinoma (11), hobnail hemangioma (11), 46 xy gonadal dysgenesis* (10), testicular gonadoblastoma (10), dopamine beta-hydroxylase deficiency (10), angiokeratoma of fordyce (10), myelodysplastic syndrome (10), hypospadias (10), rhabdoid cancer (10), fallopian tube squamous cell carcinoma (10), cytogenetically normal acute myeloid leukemia (9), congenital nephrotic syndrome finnish type (9), 46,xy partial gonadal dysgenesis* (9), sertoli cell tumor (9), nephrogenic adenofibroma (9), ewing sarcoma (9), wilson-turner syndrome (8), peritoneal serous papillary adenocarcinoma (8), sertoli-leydig cell tumor (8), gonadal dysgenesis (8), juvenile type testicular granulosa cell tumor (8), testicular granulosa cell tumor (8), endosalpingiosis (8), kidney cancer (8), iris disease (8), chancroid (8), rhabdomyosarcoma 2, alveolar (8), leiomyosarcoma (7), epithelial predominant wilms' tumor (7), kidney sarcoma (7), end stage renal failure (7), hematologic cancer (7), caudal regression syndrome (7), kidney rhabdoid cancer (7), peritoneal serous adenocarcinoma (7), melanomatosis (7), small cell osteogenic sarcoma (7), familial nephrotic syndrome (7), sarcomatosis (7), chronic eosinophilic leukemia (6), epithelioid cell melanoma (6), peritoneum cancer (6), crescentic glomerulonephritis (6), testicular leukemia (6), breast giant fibroadenoma (6), venous hemangioma (6), hypereosinophilic syndrome, idiopathic, resistant to imatinib (6), breast mucinous carcinoma (6), spindle cell liposarcoma (5), cauda equina neoplasm (5), myeloid leukemia (5), adult fibrosarcoma (5), mayer-rokitansky-kuster-hauser syndrome (5), heart sarcoma (5), pneumatosis cystoides intestinalis (5), hemihypertrophy (5), ovarian mucinous neoplasm (5), malignant epithelial mesothelioma (5), core binding factor acute myeloid leukemia (5), kidney clear cell sarcoma (5), ovary epithelial cancer (5), malignant ovarian surface epithelial-stromal neoplasm (5), botryoid rhabdomyosarcoma (5), dysgerminoma of ovary (5), premature ovarian failure 1 (5), syndromic x-linked intellectual disability (5), pleural cancer (5), urethral diverticulum (4), kidney disease (4), chondrosarcoma, extraskeletal myxoid (4), persistent mullerian duct syndrome (4), proliferative fasciitis (4), acquired thrombocytopenia (4), bone ewing's sarcoma (4), malignant mesenchymoma (3), leukemia, chronic myeloid, somatic (3), cryptorchidism (3), beckwith-wiedemann syndrome (2), ovarian cancer, somatic (2), renal cell carcinoma (2), leukemia, acute lymphoblastic (2), muscle cancer (1), connective tissue cancer (1), renal cell carcinoma, papillary (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene
  • D001564 Benzo(a)pyrene
  • D004958 Estradiol
  • D009569 Nitric Oxide
  • D014212 Tretinoin
  • C017947 sodium arsenite
  • C495626 14-deoxy-11,12-didehydroandrographolide
  • C548651 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester
  • C532162 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine
  • C021296 2-ethoxyethanol
  • D015122 6-Mercaptopurine
          more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 35.65 RPKM in Uterus
Total median expression: 155.41 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -57.44179-0.321 Picture PostScript Text
3' UTR -324.501283-0.253 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR017987 - Wilms_tumour
IPR000976 - Wilms_tumour_N
IPR007087 - Znf_C2H2
IPR015880 - Znf_C2H2-like
IPR013087 - Znf_C2H2/integrase_DNA-bd

Pfam Domains:
PF00096 - Zinc finger, C2H2 type
PF02165 - Wilm's tumour protein
PF12874 - Zinc-finger of C2H2 type

SCOP Domains:
101447 - Formin homology 2 domain (FH2 domain)
57667 - beta-beta-alpha zinc fingers

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1LU6 - Model 1XF7 - NMR 2G7T - Model 2G7V - Model 2G7W - Model 2G7X - Model 2JP9 - NMR 2JPA - NMR 2PRT - X-ray 3HPJ - X-ray MuPIT 3MYJ - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on P19544
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGD    
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000981 RNA polymerase II transcription factor activity, sequence-specific DNA binding
GO:0001077 transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding
GO:0003676 nucleic acid binding
GO:0003677 DNA binding
GO:0003700 transcription factor activity, sequence-specific DNA binding
GO:0003723 RNA binding
GO:0005515 protein binding
GO:0008270 zinc ion binding
GO:0010385 double-stranded methylated DNA binding
GO:0043565 sequence-specific DNA binding
GO:0044212 transcription regulatory region DNA binding
GO:0044729 hemi-methylated DNA-binding
GO:0046872 metal ion binding
GO:0070742 C2H2 zinc finger domain binding

Biological Process:
GO:0000122 negative regulation of transcription from RNA polymerase II promoter
GO:0001570 vasculogenesis
GO:0001657 ureteric bud development
GO:0001658 branching involved in ureteric bud morphogenesis
GO:0001822 kidney development
GO:0003156 regulation of animal organ formation
GO:0006351 transcription, DNA-templated
GO:0006355 regulation of transcription, DNA-templated
GO:0006357 regulation of transcription from RNA polymerase II promoter
GO:0006366 transcription from RNA polymerase II promoter
GO:0007281 germ cell development
GO:0007356 thorax and anterior abdomen determination
GO:0007507 heart development
GO:0007530 sex determination
GO:0008285 negative regulation of cell proliferation
GO:0008380 RNA splicing
GO:0008406 gonad development
GO:0008584 male gonad development
GO:0009888 tissue development
GO:0017148 negative regulation of translation
GO:0030308 negative regulation of cell growth
GO:0030325 adrenal gland development
GO:0030539 male genitalia development
GO:0030855 epithelial cell differentiation
GO:0032835 glomerulus development
GO:0032836 glomerular basement membrane development
GO:0035802 adrenal cortex formation
GO:0043010 camera-type eye development
GO:0043065 positive regulation of apoptotic process
GO:0043066 negative regulation of apoptotic process
GO:0045892 negative regulation of transcription, DNA-templated
GO:0045893 positive regulation of transcription, DNA-templated
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:0060231 mesenchymal to epithelial transition
GO:0060421 positive regulation of heart growth
GO:0060539 diaphragm development
GO:0060923 cardiac muscle cell fate commitment
GO:0061032 visceral serous pericardium development
GO:0071320 cellular response to cAMP
GO:0071371 cellular response to gonadotropin stimulus
GO:0072075 metanephric mesenchyme development
GO:0072112 glomerular visceral epithelial cell differentiation
GO:0072166 posterior mesonephric tubule development
GO:0072207 metanephric epithelium development
GO:0072284 metanephric S-shaped body morphogenesis
GO:0072302 negative regulation of metanephric glomerular mesangial cell proliferation
GO:2000020 positive regulation of male gonad development
GO:2000195 negative regulation of female gonad development
GO:2001076 positive regulation of metanephric ureteric bud development

Cellular Component:
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005730 nucleolus
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0016607 nuclear speck


-  Descriptions from all associated GenBank mRNAs
  BC032861 - Homo sapiens Wilms tumor 1, mRNA (cDNA clone MGC:33649 IMAGE:4827849), complete cds.
BC046461 - Homo sapiens Wilms tumor 1, mRNA (cDNA clone IMAGE:5169770), partial cds.
X51630 - Human Wilms tumor WT1 mRNA for zinc finger protein, Krueppel-like.
HW088323 - WO 2013018778-A/1: Cell for immunetherapy containing engineered nucleic acid construct encording Wilms tumor 1 gene product or fragment thereof, method for producing the cell, and the nucleic acid construct.
JC603638 - Sequence 2 from Patent EP2738253.
AK093168 - Homo sapiens cDNA FLJ35849 fis, clone TESTI2006940, highly similar to Wilms' tumor protein (WT33).
AB971668 - Homo sapiens WT1 mRNA for Wilms tumor protein isoform Ex4a(+), complete cds.
M30393 - Human Wilms' tumor (WT33) protein mRNA, 3' end.
JD232717 - Sequence 213741 from Patent EP1572962.
JD343696 - Sequence 324720 from Patent EP1572962.
JD349279 - Sequence 330303 from Patent EP1572962.
AK291736 - Homo sapiens cDNA FLJ77569 complete cds, highly similar to Homo sapiens Wilms tumor 1 (WT1), transcript variant B, mRNA.
JD120134 - Sequence 101158 from Patent EP1572962.
JD243771 - Sequence 224795 from Patent EP1572962.
JD243772 - Sequence 224796 from Patent EP1572962.
JD187490 - Sequence 168514 from Patent EP1572962.
JD299571 - Sequence 280595 from Patent EP1572962.
JD539002 - Sequence 520026 from Patent EP1572962.
JD239957 - Sequence 220981 from Patent EP1572962.
JD150433 - Sequence 131457 from Patent EP1572962.
JD420606 - Sequence 401630 from Patent EP1572962.
DD462527 - A METHOD FOR DESIGNING FLUORESCENCE RESONANT ENERGY TRANSFER PROBES.
JD347615 - Sequence 328639 from Patent EP1572962.
JD547107 - Sequence 528131 from Patent EP1572962.
JD499999 - Sequence 481023 from Patent EP1572962.
S75264 - Homo sapiens Wilms' tumor suppressor protein (WT1) mRNA, partial cds.
JF432657 - Synthetic construct Homo sapiens clone IMAGE:100073895 Wilms tumor 1 (WT1) gene, encodes complete protein.
KJ897743 - Synthetic construct Homo sapiens clone ccsbBroadEn_07137 WT1 gene, encodes complete protein.
HW088326 - WO 2013018778-A/4: Cell for immunetherapy containing engineered nucleic acid construct encording Wilms tumor 1 gene product or fragment thereof, method for producing the cell, and the nucleic acid construct.
JC603641 - Sequence 5 from Patent EP2738253.
HW088325 - WO 2013018778-A/3: Cell for immunetherapy containing engineered nucleic acid construct encording Wilms tumor 1 gene product or fragment thereof, method for producing the cell, and the nucleic acid construct.
JC603640 - Sequence 4 from Patent EP2738253.
S74529 - EWS...WT1 [human, desmoplastic small round cell tumor cells, mRNA Partial Mutant, 3 genes, 268 nt].
JD458723 - Sequence 439747 from Patent EP1572962.
JD536419 - Sequence 517443 from Patent EP1572962.
JD097748 - Sequence 78772 from Patent EP1572962.
JD450904 - Sequence 431928 from Patent EP1572962.
JD226611 - Sequence 207635 from Patent EP1572962.
JD255417 - Sequence 236441 from Patent EP1572962.
JD382502 - Sequence 363526 from Patent EP1572962.
MH550345 - Homo sapiens Wilms tumor 1 (WT1) mRNA, partial cds.

-  Biochemical and Signaling Pathways
  BioCarta from NCI Cancer Genome Anatomy Project
h_tidPathway - Chaperones modulate interferon Signaling Pathway
h_tertpathway - Overview of telomerase protein component gene hTert Transcriptional Regulation

-  Other Names for This Gene
  Alternate Gene Symbols: A8K6S1, B3KSA5, ENST00000452863.1, ENST00000452863.2, ENST00000452863.3, ENST00000452863.4, ENST00000452863.5, ENST00000452863.6, ENST00000452863.7, ENST00000452863.8, ENST00000452863.9, NM_024426, P19544, Q15881, Q16256, Q16575, Q4VXV4, Q4VXV5, Q4VXV6, Q8IYZ5, uc320uco.1, uc320uco.2, WT1_HUMAN
UCSC ID: ENST00000452863.10_10
RefSeq Accession: NM_024426.6
Protein: P19544 (aka WT1_HUMAN)

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene WT1:
cdh-ov (Congenital Diaphragmatic Hernia Overview)
wilms-ov (Wilms Tumor Predisposition)
wt1-dis (WT1 Disorder)
xxms (Nonsyndromic 46,XX Testicular Disorders/Differences of Sex Development)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.